Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Response to FCA Statement

28 Mar 2014 16:43

RNS Number : 5058D
Phoenix Group Holdings
28 March 2014
 



 

Phoenix Group Holdings ("Phoenix") response to FCA statement

 

 

Phoenix notes the statement issued by the FCA earlier today regarding a thematic review into the fair treatment of longstanding or legacy customers within closed life funds.

 

Although little detail has been provided regarding the scope and nature of any review, Phoenix makes the following observations:

 

· The FCA has stated that the review will not consider the suitability of historic advice, nor will it require a review of individual policies.

· The review will look at the level of servicing provided to policyholders whose policies are managed within closed life funds. Phoenix welcomes this review as we continue to look for areas where we can deliver better levels of customer service. We have achieved significant policy administration migrations to newer and better systems resulting in improved customer service. We regularly review our full product set to ensure it is operating as intended and remain committed to maintaining our focus on the governance of our products.

· Phoenix does not write new products (other than vesting annuities) and therefore we do not believe that any review of cross-subsidisation (in particular of the cost of new products) would be relevant to Phoenix.

· Furthermore, should the review look at the charging structures on historic policies, we are confident that our historic charging structures, including exit charges, have been compliant and in accordance with our commitments to our policyholders.

 

The press speculation regarding the thematic review follows two previous issues which have impacted the life assurance market over the last two weeks:

 

· The first of these issues was the announcement by the Chancellor in the Budget last week that policyholders would no longer be required to convert their pensions into an annuity on retirement. As explained in our full year results announcement, issued on Wednesday 26 March, we believe that this change will not have a material impact on Phoenix.

· Yesterday the Government announced a cap for all workplace pension schemes for auto enrolment. It is estimated that the cost of applying the cap to our schemes could have a maximum impact on our MCEV of £40 million.

 

In response to the statement from the FCA, Clive Bannister (Phoenix CEO) commented:

 

"Policyholders are central to everything that we do at Phoenix and we remain focussed on improving our performance and service. We aim to treat our policyholders fairly at all times. Operationally, we continue to streamline and modernise the business for the benefit of our policyholders. For example, in 2013 we increased the distributable estate by £565 million, with around 115,000 policyholders benefiting from £157 million of estate distributed in that year.

 

As our recent full-year results amply demonstrate, Phoenix is performing extremely well. This week we announced our highest ever cash generation (£817 million) and MCEV of £2.4 billion. We remain confident in the outlook for the Group.

 

We note that the review will not apply "current standards retrospectively" but is designed to "assess whether there is an issue that requires any action".

 

We will of course co-operate fully with any review conducted by the FCA."

 

We will update the market when we have greater clarity on the scope and nature of the review.

 

 

 

 

Enquiries

 

Investors / analysts

Sam Perowne

Head of Investor Relations, Phoenix Group

+44 (0)20 3735 0021

 

Media

Neil Bennett, Peter Ogden, Tom Eckersley,

Maitland

+44 (0)20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQKFDNABKDFNB
Date   Source Headline
2nd May 201810:02 amRNSDirectorate Change
30th Apr 20184:15 pmRNSTotal Voting Rights
24th Apr 20183:45 pmRNSPublication of a Prospectus
19th Apr 201810:15 amRNSPre Stabilisation Notice
18th Apr 20184:34 pmRNSPublication of a Prospectus
13th Apr 20187:00 amRNSRestricted Tier 1 Roadshow Announcement
6th Apr 20184:00 pmRNSBlock listing Interim Review
6th Apr 20184:00 pmRNSDirector/PDMR Shareholding
29th Mar 20182:00 pmRNSTotal Voting Rights
27th Mar 20184:23 pmRNSNotice of AGM
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAnnual Financial Report
7th Mar 201810:30 amRNSDirector/PDMR Shareholding
28th Feb 201811:00 amRNSTotal Voting Rights
27th Feb 20182:30 pmRNSHolding(s) in Company
23rd Feb 20187:01 amRNSAcquisition of Standard Life Assurance
12th Feb 20189:00 amRNSHolding(s) in Company
12th Feb 20189:00 amRNSDirector/PDMR Shareholding
31st Jan 201811:45 amRNSTotal Voting Rights
30th Jan 20187:00 amRNSResidency Update
29th Dec 20171:00 pmRNSHolding(s) in Company
29th Dec 20171:00 pmRNSTotal Voting Rights
19th Dec 20175:00 pmRNSHolding(s) in Company
6th Dec 20174:30 pmRNSDirector/PDMR Shareholding
4th Dec 20174:00 pmRNSDirector Declaration
30th Nov 20174:00 pmRNSTotal Voting Rights
28th Nov 20174:30 pmRNSHolding(s) in Company
8th Nov 20175:20 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:45 pmRNSHolding(s) in Company
31st Oct 20173:00 pmRNSTotal Voting Rights
27th Oct 20174:30 pmRNSHolding(s) in Company
27th Oct 20174:30 pmRNSHolding(s) in Company
20th Oct 20174:30 pmRNSHolding(s) in Company
18th Oct 20174:45 pmRNSHolding(s) in Company
16th Oct 20174:30 pmRNSHolding(s) in Company
13th Oct 20174:15 pmRNSHolding(s) in Company
9th Oct 20174:00 pmRNSBlock listing Interim Review
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
4th Oct 20174:45 pmRNSDirector/PDMR Shareholding
29th Sep 20173:00 pmRNSTotal Voting Rights
13th Sep 20174:30 pmRNSPublication of Suppl.Prospcts
12th Sep 20179:15 amRNSHolding(s) in Company
12th Sep 20179:15 amRNSHolding(s) in Company
7th Sep 20173:30 pmRNSDirector/PDMR Shareholding
31st Aug 20174:45 pmRNSHolding(s) in Company
31st Aug 20174:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNS2017 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.